| NATERA INC. DL-,0001 |
| USA |
| Gesundheit |
| US6323071042 / A14VPJ |
| 45E (Frankfurt) / NTRA (NASDAQ) |
| FRA:45E, ETR:45E, 45E:GR, NASDAQ:NTRA |
| - |
| https://www.natera.com/ |
|
Natera Inc. is a diagnostics company specializing in the discovery, development, and commercialization of genetic testing services powered by proprietary molecular and bioinformatics technology. Its primary offerings include the Panorama non-invasive..
>Volltext.. |
| 25536.54 Mio. EUR |
| 24789.98 Mio. EUR |
| 1997.82 Mio. EUR |
| -227.43 Mio. EUR |
| -180.33 Mio. EUR |
| -1.33 EUR |
| 185.72 Mio. EUR |
| 932.28 Mio. EUR |
| 186.52 Mio. EUR |
| 2.44 |
| 35.9% |
| -9.31% |
| - |
| - |
| - |
| 8 Insider verkauften innerhalb der letzten 30 Tage Aktien im Wert von 45.197.763 USD. |
| NATERA |
| 05.04.26 |